Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP867975.RA2nY8syAYjUeCuWJVOPC8mvZUPYl7waexhVhPTSy2FZ4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP867975.RA2nY8syAYjUeCuWJVOPC8mvZUPYl7waexhVhPTSy2FZ4130_assertion type Assertion NP867975.RA2nY8syAYjUeCuWJVOPC8mvZUPYl7waexhVhPTSy2FZ4130_head.
- NP867975.RA2nY8syAYjUeCuWJVOPC8mvZUPYl7waexhVhPTSy2FZ4130_assertion description "[The findings indicate that TGFBR2 gene mutations are responsible for sCAD in 3.6% (95% CI 0.0 to 8.4) of cases, have implications in understanding the role of TGF? signalling in the pathogenesis of sCAD and emphasise the importance of considering molecular characterisation of the TGFBR2 gene in these patients, regardless of the presence of clinical features suggestive of hereditary connective tissue disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP867975.RA2nY8syAYjUeCuWJVOPC8mvZUPYl7waexhVhPTSy2FZ4130_provenance.
- NP867975.RA2nY8syAYjUeCuWJVOPC8mvZUPYl7waexhVhPTSy2FZ4130_assertion evidence source_evidence_literature NP867975.RA2nY8syAYjUeCuWJVOPC8mvZUPYl7waexhVhPTSy2FZ4130_provenance.
- NP867975.RA2nY8syAYjUeCuWJVOPC8mvZUPYl7waexhVhPTSy2FZ4130_assertion SIO_000772 21270064 NP867975.RA2nY8syAYjUeCuWJVOPC8mvZUPYl7waexhVhPTSy2FZ4130_provenance.
- NP867975.RA2nY8syAYjUeCuWJVOPC8mvZUPYl7waexhVhPTSy2FZ4130_assertion wasDerivedFrom befree-2016 NP867975.RA2nY8syAYjUeCuWJVOPC8mvZUPYl7waexhVhPTSy2FZ4130_provenance.
- NP867975.RA2nY8syAYjUeCuWJVOPC8mvZUPYl7waexhVhPTSy2FZ4130_assertion wasGeneratedBy ECO_0000203 NP867975.RA2nY8syAYjUeCuWJVOPC8mvZUPYl7waexhVhPTSy2FZ4130_provenance.